ZA9810774B - Use of P102 as a recombinant mycoplasma hypopneumoniae vaccine - Google Patents

Use of P102 as a recombinant mycoplasma hypopneumoniae vaccine

Info

Publication number
ZA9810774B
ZA9810774B ZA9810774A ZA9810774A ZA9810774B ZA 9810774 B ZA9810774 B ZA 9810774B ZA 9810774 A ZA9810774 A ZA 9810774A ZA 9810774 A ZA9810774 A ZA 9810774A ZA 9810774 B ZA9810774 B ZA 9810774B
Authority
ZA
South Africa
Prior art keywords
vaccine
recombinant mycoplasma
hypopneumoniae
mycoplasma hypopneumoniae
recombinant
Prior art date
Application number
ZA9810774A
Other languages
English (en)
Inventor
Chris F Minion
Tshungda Hsu
Original Assignee
Univ Iowa State Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa State Res Found Inc filed Critical Univ Iowa State Res Found Inc
Publication of ZA9810774B publication Critical patent/ZA9810774B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA9810774A 1997-11-26 1998-11-25 Use of P102 as a recombinant mycoplasma hypopneumoniae vaccine ZA9810774B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6656597P 1997-11-26 1997-11-26

Publications (1)

Publication Number Publication Date
ZA9810774B true ZA9810774B (en) 1999-05-26

Family

ID=22070298

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810774A ZA9810774B (en) 1997-11-26 1998-11-25 Use of P102 as a recombinant mycoplasma hypopneumoniae vaccine

Country Status (13)

Country Link
US (1) US6162435A (zh)
EP (1) EP1034004A1 (zh)
JP (1) JP2001523481A (zh)
KR (1) KR20010032493A (zh)
CN (1) CN1301180A (zh)
AU (1) AU1535299A (zh)
BR (1) BR9815321A (zh)
CA (1) CA2311759A1 (zh)
HU (1) HUP0100130A2 (zh)
ID (1) ID26951A (zh)
PL (1) PL341797A1 (zh)
WO (1) WO1999026664A1 (zh)
ZA (1) ZA9810774B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210804A (pt) 2001-07-02 2005-05-03 Pfizer Prod Inc Vacinação de dose única com mycoplásma hyopneumoniae
DK1546357T3 (da) * 2002-06-28 2013-09-02 Univ Iowa State Res Found Inc Immunogene polypeptider af mycoplasma pneumoniae
DK2609428T3 (en) * 2010-08-27 2016-05-17 Intervet Int Bv STRENGTH TEST FOR VACCINE FORMULATIONS
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
KR101503907B1 (ko) * 2013-01-17 2015-03-20 서울대학교산학협력단 흉막폐렴균과 마이코플라즈마 하이오뉴모니아 감염 질환 예방을 위한 재조합 단백질 백신
BR112016006192A2 (pt) 2013-09-25 2017-09-26 Zoetis Services Llc composição de vacina de divergente de pcv2b e métodos de uso
CN108623663B (zh) * 2018-05-14 2021-09-21 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猪肺炎支原体p97蛋白的免疫原性功能多肽及其编码基因和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170646A (en) * 1978-07-17 1979-10-09 American Cyanamid Company Method for the control of Mycoplasma hyopneumoniae in swine with alkylated BM123γ type antibiotics
FR2578859B1 (fr) * 1985-03-12 1989-09-08 Commissariat Energie Atomique Appareillage et installation de realisation d'un depot metallique electrolytique d'epaisseur constante.
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US5252328A (en) * 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
US5240706A (en) * 1989-04-07 1993-08-31 Ml Technology Ventures, L.P. Intranasal administration of Mycoplasma hyopneumoniae antigen
EP0527771A4 (en) * 1990-04-02 1993-05-05 Synergen, Inc. Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5712090A (en) * 1993-05-18 1998-01-27 Iowa State University Research Foundation, Inc. PCR-based assay for Mycoplasma hyopneumoniae
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures

Also Published As

Publication number Publication date
EP1034004A1 (en) 2000-09-13
KR20010032493A (ko) 2001-04-25
US6162435A (en) 2000-12-19
ID26951A (id) 2001-02-22
AU1535299A (en) 1999-06-15
CA2311759A1 (en) 1999-06-03
JP2001523481A (ja) 2001-11-27
PL341797A1 (en) 2001-05-07
WO1999026664A1 (en) 1999-06-03
HUP0100130A2 (hu) 2001-05-28
BR9815321A (pt) 2002-01-02
CN1301180A (zh) 2001-06-27

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
PL341761A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
ZA978868B (en) Vaccine composition
EP0717636A4 (en) RECOMBINANT MALARIA POXVIRUS VACCINE
GB2330883B (en) Protective bellows
GB9616351D0 (en) Vaccine composition
GB9623233D0 (en) Vaccine composition
GB9401787D0 (en) Vaccine compositions
ZA9810774B (en) Use of P102 as a recombinant mycoplasma hypopneumoniae vaccine
GB9706930D0 (en) Leishmania vaccine
AU6715094A (en) Recombinant vaccine
GB9413751D0 (en) Immunodominant peptides
ZA982763B (en) Vaccines
AU2232399A (en) Recombinant ctb-based vaccines
GB9417880D0 (en) Vaccine
GB9419969D0 (en) Vaccine
GB9720982D0 (en) Vaccine
GB9718902D0 (en) Vaccine
GB9717423D0 (en) Vaccine
GB9700896D0 (en) S-blocked glutathiones
GB9601739D0 (en) Vaccine Compositions